Josh Canavan

Josh Canavan is the head of pharmacy at RazorMetrics.

Articles by Josh Canavan

Scientist analyzing biosimilars for quality and efficacy, drug comparison, pharmaceutical standards | © Photo18@desing - stock.adobe.com (952831370)

From Promise to Proof: The Shakeup in Today’s Biosimilar Market

May 19th 2026

Latest Updated Articles

Trending on Pharmaceutical Commerce

How Precision and Share of Answer Will Reshape Pharma Marketing

How Lanes and Duration Shape Cold Chain Packaging Selection

Smart Locks, Escorts or Parcel? Matching Security to the Shipment

Supply Chain Visibility Needs Context Before AI, Says PAXAFE’s Mark Talens

Why Securing Pharma Freight Starts With Broker and Carrier SOPs